These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30604657)

  • 1. Low prevalence of substance use in people with 22q11.2 deletion syndrome.
    Vingerhoets C; van Oudenaren MJF; Bloemen OJN; Boot E; van Duin EDA; Evers LJM; Fiksinski AM; Breetvelt EJ; Palmer LD; Vergaelen E; Vogels A; Meijer C; Booij J; ; de Haan L; Swillen A; Vorstman JAS; Bassett AS; van Amelsvoort TAMJ
    Br J Psychiatry; 2019 Nov; 215(5):661-667. PubMed ID: 30604657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
    Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
    JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
    Tang SX; Gur RE
    Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
    Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Armando M; Lin A; Pontillo M; Vicari S
    Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
    Radoeva PD; Fremont W; Antshel KM; Kates WR
    Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal
    van Hooijdonk CFM; Tse DHY; Roosenschoon J; Ceccarini J; Booij J; van Amelsvoort TAMJ; Vingerhoets C
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural correlates of reward processing in adults with 22q11 deletion syndrome.
    van Duin EDA; Goossens L; Hernaus D; da Silva Alves F; Schmitz N; Schruers K; van Amelsvoort T
    J Neurodev Disord; 2016; 8():25. PubMed ID: 27429661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.
    Bagautdinova J; Zöller D; Schaer M; Padula MC; Mancini V; Schneider M; Eliez S
    Mol Psychiatry; 2021 Dec; 26(12):7671-7678. PubMed ID: 34253864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
    Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
    Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
    Antshel KM; Fremont W; Ramanathan S; Kates WR
    Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
    van Duin EDA; Kasanova Z; Hernaus D; Ceccarini J; Heinzel A; Mottaghy F; Mohammadkhani-Shali S; Winz O; Frank M; Beck MCH; Booij J; Myin-Germeys I; van Amelsvoort T
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):732-742. PubMed ID: 29703646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive functions and memory abilities in children with 22q11.2 deletion syndrome.
    Campbell LE; Azuma R; Ambery F; Stevens A; Smith A; Morris RG; Murphy DG; Murphy KC
    Aust N Z J Psychiatry; 2010 Apr; 44(4):364-71. PubMed ID: 20307169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower [
    van Duin EDA; Ceccarini J; Booij J; Kasanova Z; Vingerhoets C; van Huijstee J; Heinzel A; Mohammadkhani-Shali S; Winz O; Mottaghy F; Myin-Germeys I; van Amelsvoort T
    Psychol Med; 2020 Apr; 50(5):799-807. PubMed ID: 30935427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
    Fiksinski AM; Breetvelt EJ; Duijff SN; Bassett AS; Kahn RS; Vorstman JAS
    Schizophr Res; 2017 Oct; 188():59-62. PubMed ID: 28119035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.
    Vorstman JA; Turetsky BI; Sijmens-Morcus ME; de Sain MG; Dorland B; Sprong M; Rappaport EF; Beemer FA; Emanuel BS; Kahn RS; van Engeland H; Kemner C
    Neuropsychopharmacology; 2009 Feb; 34(3):739-46. PubMed ID: 18769474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.